IQSEC3: A Protein Implicated in Cancer and Other Diseases (G440073)

Target Name: IQSEC3

NCBI ID: G440073

IQSEC3

IQSEC3: A Protein Implicated in Cancer and Other Diseases

IQSEC3 (IQSEC3 variant 2) is a protein that is expressed in the human placenta and has been shown to play a role in the development and progression of various diseases, including cancer. It is also a potential drug target or biomarker for the treatment of these diseases.

The IQSEC3 protein is a member of the Integrin alpha-2 (Igp2) family, which is a type of transmembrane protein that is involved in many different processes in the body, including cell adhesion, migration, and signaling. It is composed of four subunits , which are held together by disulfide bonds.

IQSEC3 has been shown to be involved in the regulation of cell adhesion and migration. It is a critical protein for the development and maintenance of neural stem cells, which are a type of cell that have the ability to develop into any type of cell in the nervous system. In addition, IQSEC3 is also shown to be involved in the regulation of stem cell proliferation and differentiation.

IQSEC3 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important for the development of many diseases, including cancer.

In addition to its role in cell regulation, IQSEC3 has also been shown to be involved in the regulation of the immune system. It is a critical protein for the development and maintenance of natural killer cells, which are a type of immune cell that play an important role in fighting off infections and diseases.

IQSEC3 has also been shown to be involved in the regulation of inflammation. This is important for the development and progression of many diseases, including cancer.

Despite its involvement in so many different processes in the body, IQSEC3 is still not well understood. little is known about the specific functions of this protein, and much of its behavior remains mysterious. However, its potential as a drug target or biomarker makes it a promising target for the development of new treatments for a wide range of diseases.

In conclusion, IQSEC3 (IQSEC3 variant 2) is a protein that is expressed in the human placenta and has been shown to play a role in the development and progression of various diseases, including cancer. It is also a potential drug target or biomarker for the treatment of these diseases. Further research is needed to fully understand the specific functions of this protein and its potential as a therapeutic target.

Protein Name: IQ Motif And Sec7 Domain ArfGEF 3

Functions: Acts as a guanine nucleotide exchange factor (GEF) for ARF1

The "IQSEC3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IQSEC3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets